Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders

被引：8

作者：

Bagnasco, Diego ^{[1
,2
]}

Nicola, Stefania ^{[3
]}

Testino, Elisa ^{[1
,2
]}

Brussino, Luisa ^{[3
]}

Pini, Laura ^{[4
]}

Caminati, Marco ^{[5
]}

Piccardo, Federica ^{[2
]}

Canevari, Rikki Frank ^{[6
]}

Melissari, Laura ^{[1
,2
]}

Ioppi, Alessandro ^{[6
]}

Guastini, Luca ^{[6
]}

Lombardi, Carlo ^{[7
]}

Milanese, Manlio ^{[8
]}

Losa, Francesca ^{[9
]}

Robbiano, Michela ^{[1
,2
]}

De Ferrari, Laura ^{[1
,2
]}

Riccio, Anna Maria ^{[1
,2
]}

Guida, Giuseppe ^{[10
]}

Bonavia, Marco ^{[11
]}

Fini, Donatella ^{[12
]}

Balbi, Francesco ^{[13
]}

Caruso, Cristiano ^{[14
]}

Paggiaro, Pierluigi ^{[15
]}

Blasi, Francesco ^{[16
,17
,18
]}

Heffler, Enrico ^{[19
,20
]}

Paoletti, Giovanni ^{[19
,20
]}

Canonica, Giorgio Walter ^{[19
,20
]}

Senna, Gianenrico ^{[5
]}

Passalacqua, Giovanni ^{[1
,2
]}

机构：

[1] Univ Genoa, IRCCS Policlin San Martino, Allergy & Resp Dis, I-16132 Genoa, Italy

[2] Univ Genoa, Dept Internal Med DIMI, I-16132 Genoa, Italy

[3] AO Ordine Mauriziano Torino, SCDU Immunol & Allergol, Cso Re Umberto 109, I-10128 Turin, Italy

[4] Spedali Civili Brescia, Resp Med Unit, Piazzale Spedali Civili 1, I-25123 Brescia, Italy

[5] Univ Verona, Dept Med, I-37134 Verona, Italy

[6] Univ Genoa, ENT Dept, IRCCS Policlin San Martino, I-16132 Genoa, Italy

[7] Fdn Poliambulanza, Dept Unit Allergol Immunol & Pulm Dis, I-25124 Brescia, Italy

[8] ASL2, S Corona Hosp, Dept Resp Dis, I-17027 Pietra Ligure, Italy

[9] ASST Mantova, UO Allergol & Clin Immunol, I-46100 Mantua, Italy

[10] Univ Torino, Dept Clin & Biol Sci, Orbassano 10043, Italy

[11] ASL3, Hosp Ge Arenzano, Dept Rehabil Pulmonol, I-16149 Genoa, Italy

[12] Hosp Sarzana SP, Dept Pneumol, I-19125 La Spezia, Italy

[13] Hosp Imperia, Dept Pneumol, I-18100 Imperia, Italy

[14] Univ Cattolica Sacro Cuore, Dept Med & Surg Sci, Fdn Universitary Policlin A Gemelli IRCCS, I-20123 Rome, Italy

[15] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Care, I-56126 Pisa, Italy

[16] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy

[17] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Resp Unit, I-20122 Milan, Italy

[18] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Adult Cyst Fibrosis Ctr, Internal Med Dept, I-20122 Milan, Italy

[19] IRCCS Human Clin & Res Hosp, Unit Personalized Med Asthma & Allergy, I-20089 Rozzano, Italy

[20] Humanitas Univ, Dept Biomed Sci, I-20072 Pieve Emanuele, Italy

来源：

BIOMEDICINES | 2023年 / 11卷 / 09期

关键词：

severe asthma; eosinophils; mepolizumab; CRSwNP; IL-5; real life; registry; SEVERE EOSINOPHILIC ASTHMA; MULTICENTER;

D O I：

10.3390/biomedicines11092424

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The efficacy mepolizumab in severe asthmatic patients is proven in the literature. Primarily to study the effect of mepolizumab on exacerbations, steroid dependence, and the continuation of efficacy in the long term. Secondarily to evaluate the effect of the drug on nasal polyps. Analyzing data from SANI (Severe Asthma Network Italy) clinics, we observed severe asthmatic patients treated with mepolizumab 100 mg/4 weeks, for a period of 3 years. 157 patients were observed. Exacerbations were reduced from the first year (-84.6%) and progressively to 90 and 95% in the second and third ones. Steroid-dependent patients decreased from 54% to 21% and subsequently to 11% in the second year and 6% in the third year. Patients with concomitant nasal polyps, assessed by SNOT-22, showed a 49% reduction in value from baseline to the third year. The study demonstrated the long-term efficacy of mepolizumab in a real-life setting.

引用

页数：10

共 50 条

[31] Omalizumab as a long-term treatment for patients with severe asthma. Is it safe?: A ten-year study
Habeb, Mohamed
Elhawary, Abeer
Hamed, Mohamed S.
Zayed, Niveen E.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2024, 73 (01): : 7 - 12
[32] Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study
Quarato, Carla Maria Irene
Tondo, Pasquale
Lacedonia, Donato
Soccio, Piera
Fuso, Paolo
Sabato, Eugenio
Hoxhallari, Anela
Foschino Barbaro, Maria Pia
Scioscia, Giulia
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
[33] Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment
Busse, William W.
Bleecker, Eugene R.
FitzGerald, J. Mark
Ferguson, Gary T.
Barker, Peter
Brooks, Laura
Olsson, Richard F.
Martin, Ubaldo J.
Goldman, Mitchell
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (01) : 266 - +
[34] Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasis
Leonardi, C.
Papp, K.
Strober, B.
Thaci, D.
Warren, R. B.
Tyring, S.
Arikan, D.
Karunaratne, M.
Valdecantos, W. C.
BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (01) : 76 - 85
[35] Long-term efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: a propensity score matching analysis in the multicenter REVEAL cohort study
Shiomi, Mayu
Watanabe, Ryu
Matsuda, Shogo
Kotani, Takuya
Okazaki, Ayana
Masuda, Yuichi
Yoshida, Tsuneyasu
Shoji, Mikihito
Tsuge, Ryosuke
Kadoba, Keiichiro
Hiwa, Ryosuke
Yamamoto, Wataru
Takeda, Akitoshi
Itoh, Yoshiaki
Hashimoto, Motomu
FRONTIERS IN IMMUNOLOGY, 2024, 15
[36] Long-term efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis
Zheng, Jianfeng
Chen, Wenjuan
Yi, Xuemei
Yu, Ning
Ding, Yangfeng
Gao, Yunlu
FRONTIERS IN MEDICINE, 2023, 10
[37] Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
Huang, Yanran
Wang, Chengshuo
Cao, Feifei
Zhao, Yan
Lou, Hongfei
Zhang, Luo
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (01) : 68 - 78
[38] Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review
Colombo, Giorgio Lorenzo
Di Matteo, Sergio
Martinotti, Chiara
Oselin, Martina
Valentino, Maria Chiara
Bruno, Giacomo Matteo
Pitotti, Claudia
Menzella, Francesco
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
[39] BIMEKIZUMAB LONG-TERM EFFICACY IN PATIENTS WITH PLAQUE PSORIASIS FROM BE BRIGHT: MEAN PERCENTAGE IMPROVEMENT IN CLINICAL OUTCOMES OVER 4 YEARS
Gerdes, Sascha
Costanzo, Antonio
Fernandez-Penas, Pablo
Asadullah, Khusru
Blauvelt, Andrew
Gonzalez-Cantero, Alvaro
Kavanagh, Sarah
Pinto, Jose Manuel Lopez
Hoepken, Bengt
Han, George
ACTA DERMATO-VENEREOLOGICA, 2024, 104
[40] Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Huffman, Brandon M.
Singh, Harshabad
Ali, Lestat R.
Horick, Nora
Wang, S. Jennifer
Hoffman, Megan T.
Metayer, Katherine A.
Murray, Shayla
Bird, Alexandra
Abrams, Thomas A.
Biller, Leah H.
Chan, Jennifer A.
Meyerhardt, Jeffrey A.
Mccleary, Nadine J.
Goessling, Wolfram
Patel, Anuj K.
Wisch, Jeffrey S.
Yurgelun, Matthew B.
Mouw, Kent
Reardon, Brendan
Van Allen, Eliezer M.
Zerillo, Jessica A.
Clark, Jeffrey W.
Parikh, Aparna
Mayer, Robert J.
Schlechter, Benjamin
Ng, Kimmie
Kumar, Sunil
Fitz, Catherine Del Vecchio
Kuperwasser, Charlotte
Hanna, Glenn J.
Coveler, Andrew L.
Rubinson, Douglas A.
Welsh, Emma L.
Pfaff, Kathleen
Rodig, Scott
Dougan, Stephanie K.
Cleary, James M.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)

← 1 2 3 4 5 →